<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2023-9-3-0-8</article-id><article-id pub-id-type="publisher-id">3168</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medicine (miscellaneous)</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Biological age as a risk factor for ophthalmological complications in type 2 diabetes mellitus&lt;/strong&gt;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Biological age as a risk factor for ophthalmological complications in type 2 diabetes mellitus&lt;/strong&gt;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Agarkov</surname><given-names>Nikolai M.</given-names></name><name xml:lang="en"><surname>Agarkov</surname><given-names>Nikolai M.</given-names></name></name-alternatives><email>vitalaxen@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Lev</surname><given-names>Inna V.</given-names></name><name xml:lang="en"><surname>Lev</surname><given-names>Inna V.</given-names></name></name-alternatives><email>michina.inna@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Kopylov</surname><given-names>Andrey E.</given-names></name><name xml:lang="en"><surname>Kopylov</surname><given-names>Andrey E.</given-names></name></name-alternatives><email>mntk@mntk-tambov.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2023</year></pub-date><volume>9</volume><issue>3</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2023/3/НРБИ_2023_3-96-105.pdf" /><abstract xml:lang="ru"><p>Background:&amp;nbsp;An increase in the incidence of type 2 diabetes mellitus in many countries is simultaneously accompanied by an increase in the frequency of diabetic retinopathy, which is the most dangerous complication of type 2 diabetes mellitus. Biological age may be one of the contributing factors in the development of diabetic retinopathy, but the latter remains unexplored in such patients. The aim of the study:&amp;nbsp;To study the biological age as a risk factor for ophthalmic complications in type 2 diabetes mellitus. Materials and methods:&amp;nbsp;Among 580 45-59-year-old patients with diabetic retinopathy in type 2 diabetes mellitus, the biological age was determined by the method of Voitenko V.P. et al. [1984]. Three groups were formed: patients with matching biological and chronological age (n=124), with exceeding the chronological biological age (n=357) and with exceeding the biological chronological age (n=99). In the subsequent analysis, the first two groups were considered. The X2 criterion and the discriminant method were used in the work. Results:&amp;nbsp;Among 45-59-year-old patients with type 2 diabetes mellitus with an excess of the biological age of the chronological value, the prevalence of diabetic retinopathy was 19.82&amp;plusmn;1.32 cases per 100 examined, whereas among 45-59-year-old patients with type 2 diabetes mellitus with a correspondence of biological and chronological age &amp;ndash; 10.24&amp;plusmn;1.51 cases per 100 examined. The chronological age of diagnosis of diabetic retinopathy in the group of patients with an excess of biological age over chronological age was younger &amp;ndash; 47.69&amp;plusmn;1.24 years versus 50.23&amp;plusmn;0.92 years in the group with a correspondence of biological and chronological age (p&amp;lt;0.01). On the contrary, the biological age of diagnosis of diabetic retinopathy in the group with an excess of the chronological biological age is significantly greater &amp;ndash; 56.13&amp;plusmn;0.83 years than in the comparison group &amp;ndash; 49.61&amp;plusmn;1.11 years (p&amp;lt;0.001). By means of the discriminant method and taking into account the parameters of biological age, discriminant models have been developed to ensure the differentiation of these patients. Conclusion:&amp;nbsp;Exceeding the chronological biological age is a significant risk factor for ophthalmological complications of type 2 diabetes mellitus &amp;ndash; diabetic retinopathy in 45-59 years.</p></abstract><trans-abstract xml:lang="en"><p>Background:&amp;nbsp;An increase in the incidence of type 2 diabetes mellitus in many countries is simultaneously accompanied by an increase in the frequency of diabetic retinopathy, which is the most dangerous complication of type 2 diabetes mellitus. Biological age may be one of the contributing factors in the development of diabetic retinopathy, but the latter remains unexplored in such patients. The aim of the study:&amp;nbsp;To study the biological age as a risk factor for ophthalmic complications in type 2 diabetes mellitus. Materials and methods:&amp;nbsp;Among 580 45-59-year-old patients with diabetic retinopathy in type 2 diabetes mellitus, the biological age was determined by the method of Voitenko V.P. et al. [1984]. Three groups were formed: patients with matching biological and chronological age (n=124), with exceeding the chronological biological age (n=357) and with exceeding the biological chronological age (n=99). In the subsequent analysis, the first two groups were considered. The X2 criterion and the discriminant method were used in the work. Results:&amp;nbsp;Among 45-59-year-old patients with type 2 diabetes mellitus with an excess of the biological age of the chronological value, the prevalence of diabetic retinopathy was 19.82&amp;plusmn;1.32 cases per 100 examined, whereas among 45-59-year-old patients with type 2 diabetes mellitus with a correspondence of biological and chronological age &amp;ndash; 10.24&amp;plusmn;1.51 cases per 100 examined. The chronological age of diagnosis of diabetic retinopathy in the group of patients with an excess of biological age over chronological age was younger &amp;ndash; 47.69&amp;plusmn;1.24 years versus 50.23&amp;plusmn;0.92 years in the group with a correspondence of biological and chronological age (p&amp;lt;0.01). On the contrary, the biological age of diagnosis of diabetic retinopathy in the group with an excess of the chronological biological age is significantly greater &amp;ndash; 56.13&amp;plusmn;0.83 years than in the comparison group &amp;ndash; 49.61&amp;plusmn;1.11 years (p&amp;lt;0.001). By means of the discriminant method and taking into account the parameters of biological age, discriminant models have been developed to ensure the differentiation of these patients. Conclusion:&amp;nbsp;Exceeding the chronological biological age is a significant risk factor for ophthalmological complications of type 2 diabetes mellitus &amp;ndash; diabetic retinopathy in 45-59 years.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>biological age</kwd><kwd>chronological age</kwd><kwd>diabetes mellitus</kwd><kwd>mature age</kwd><kwd>ophthalmological complication</kwd><kwd>diabetic retinopathy risk factors</kwd></kwd-group><kwd-group xml:lang="en"><kwd>biological age</kwd><kwd>chronological age</kwd><kwd>diabetes mellitus</kwd><kwd>mature age</kwd><kwd>ophthalmological complication</kwd><kwd>diabetic retinopathy risk factors</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Dedov II., Shestakova MV, Vikulova OK, et al. Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the Federal diabetes register data of 01.01.2021. Diabetes mellitus. 2021;24(3):204-221. Russian. DOI: https://doi.org/10.14341/DM12759</mixed-citation></ref><ref id="B2"><mixed-citation>Dedov II, Mokrysheva NG, Shestakova MV, et al. Glycemia control and choice of antihyperglycemic therapy in patients with type 2 diabetes mellitus and COVID-19: a consensus decision of the board of experts of the Russian association of endocrinologists. Diabetes mellitus. 2022;25(1):27-49. Russian. DOI: https://doi.org/10.14341/DM12873</mixed-citation></ref><ref id="B3"><mixed-citation>Ting DSW, Cheung CY, Nguyen Q, et al. Deep learning in estimating prevalence and systemic risk factors for diabetic retinopathy: a multi-ethnic study. npj Digital Medicine. 2019;2:24. DOI: https://doi.org/10.1038/s41746-019-0097-x</mixed-citation></ref><ref id="B4"><mixed-citation>Murthy GVS. Situational analysis of diabetic retinopathy screening in India: How has it changed in the last three years? Indian Journal of Ophthalmology. 2021;69(11):2944-2950. DOI: https://doi.org/10.4103/ijo.ijo_1242_21</mixed-citation></ref><ref id="B5"><mixed-citation>Xie Y, Gunasekeran DV, Balaskas K, et al. Health Economic and Safety Considerations for Artificial Intelligence Applications in Diabetic Retinopathy Screening. Translational Vision Science and Technology. 2020;9(2):22. DOI: https://doi.org/10.1167/tvst.9.2.22</mixed-citation></ref><ref id="B6"><mixed-citation>Barkmeier AJ. Toward Optimal Screening for Diabetic Retinopathy: Balancing Precision and Pragmatism. Mayo Clinic Proceedings. 2021;96(2):282-284. DOI: https://doi.org/10.1016/j.mayocp.2020.12.008</mixed-citation></ref><ref id="B7"><mixed-citation>Klyosova EYu, Azarova IE, Sunyaykina OA, et al. Validity of a brief screener for environmental risk factors of age-related diseases using type 2 diabetes and coronary artery disease as examples. Research Results in Biomedicine. 2022;8(1):130-137. Russian. DOI: https://doi.org/10.18413/2658-6533-2022-8-1-0-10</mixed-citation></ref><ref id="B8"><mixed-citation>Kang Q, Yang C. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biology. 2020;37:101799. DOI: https://doi.org/10.1016/j.redox.2020.101799</mixed-citation></ref><ref id="B9"><mixed-citation>Mansour SE, Browning DJ, Wong K, et al. The Evolving Treatment of Diabetic Retinopathy. Clinical Ophthalmology. 2020;14:653-678. DOI: https://doi.org/10.2147/OPTH.S236637</mixed-citation></ref><ref id="B10"><mixed-citation>Augustine J, Troendle EP, Barabas P, et al. The Role of Lipoxidation in the Pathogenesis of Diabetic Retinopathy. Frontiers in Endocrinology. 2021;11:621938. DOI: https://doi.org/10.3389/fendo.2020.621938</mixed-citation></ref><ref id="B11"><mixed-citation>Astakhov YuS, Neroyev VV, Shestakova MV, et al. Clinical recommendations &amp;quot;Diabetes mellitus: diabetic retinopathy, diabetic macular edema&amp;quot;. Moscow: Obshcherossiyskaya obshchestvennaya organizatsiya &amp;laquo;Assotsiatsiya vrachey-oftalmologov&amp;raquo;; 2020. Russian.</mixed-citation></ref><ref id="B12"><mixed-citation>Markina LD. Determination of the biological age of a person by the method of V.P. Voitenko. Vladivostok: Vladivostok State Medical University; 2001. Russian.</mixed-citation></ref><ref id="B13"><mixed-citation>Treneva EV, Bulgakova SV, Kurmaev DP, et al. Analysis of circadian rhythms of cortisol secretion in men with signs of accelerated aging and their clinical and organizational significance. Current problems of health care and medical statistics. 2022;1:208-219. Russian. DOI: https://doi.org/10.24412/2312-2935-2022-1-213-224</mixed-citation></ref><ref id="B14"><mixed-citation>Benberin VV, Tanbayeva GZ, Iskakova SA, et al. Studying the factors influencing biological age of long-livers of Almaty. Advances in Gerontology. 2017;30(1):27-30. Russian.</mixed-citation></ref><ref id="B15"><mixed-citation>Dubashevsky RA. Biological age and aging rates of senile people and centenarians with polymorbidity. Scientific Review. Pedagogical Sciences. 2019;5(4):49-52. Russian.</mixed-citation></ref><ref id="B16"><mixed-citation>Bahour N, Cortez B, Pan H, et al. Diabetes mellitus correlates with increased biological age as indicated by clinical biomarkers. GeroScience. 2022;44(1):415-427. DOI: https://doi.org/10.1007/s11357-021-00469-0</mixed-citation></ref><ref id="B17"><mixed-citation>Glazkova PA, Krasulina KA, Glazkov A, etc. Correlation of parameters of skin microcirculation of blood with biological age in patients with diabetes mellitus. Advances in Gerontology. 2021;34(6):863-839. Russian. DOI: https://doi.org/10.34922/AE.2021.34.6.007</mixed-citation></ref></ref-list></back></article>